GB10

· Shenzhen Kexing Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GB10, covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD) [Phase 1]

See pricing